Siegfried Holding AG

Equities

SFZN

CH0014284498

Pharmaceuticals

Market Closed - Swiss Exchange 12:30:28 2024-03-28 pm EDT 5-day change 1st Jan Change
921 CHF +1.49% Intraday chart for Siegfried Holding AG +1.60% +7.16%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Siegfried Holding AG Proposes Dividend for the Year 2023 CI
Transcript : Siegfried Holding AG, 2023 Earnings Call, Feb 20, 2024
Siegfried Holding AG Reports Earnings Results for the Full Year Ended December 31, 2023 CI
US Futures Down, European Stocks Mixed, After a Quiet Session With U.S. Markets Closed on Monday DJ
Siegfried Posts Lower FY23 Attributable Profit; Net Sales Up MT
Siegfried Names Successor to Outgoing Chief Business Officer Drug Substances MT
BNP Paribas Exane Lifts Price Target on Siegfried, Maintains Outperform Recommendation MT
Stifel Lifts Price Target on Siegfried Holding AG, Maintains Hold Recommendation MT
Siegfried Holding AG Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Transcript : Siegfried Holding AG, H1 2023 Earnings Call, Aug 17, 2023
Siegfried Posts Lower H1 Net Profit; Net Sales Up MT
Octavian Lifts Price Target on Siegfried, Maintains Hold Recommendation MT
Siegfried Announces Executive Changes CI
Credit Suisse Lifts Price Target on Siegfried Holding, Maintains Outperform Recommendation MT
Siegfried Appoints Successor to Outgoing Chief Human Resources Officer MT
Bank Vontobel Lifts Price Target on Siegfried, Maintains Buy Recommendation MT
Octavian Lowers Price Target on Siegfried, Maintains Hold Recommendation MT
Transcript : Siegfried Holding AG - M&A Call
Siegfried Acquires Majority Stake in Swiss Biotech DiNAMIQS MT
Siegfried Holding AG acquired 95% stake in DiNAMIQS from DiNAQOR AG. CI
Siegfried Developing New Swiss R&D Center for Drug Substances MT
Siegfried Inaugurates Drug Products Development Center in Barcelona, Spain MT
Baader Helvea Lowers Price Target on Siegfried Holding, Maintains Buy Recommendation MT
BNP Paribas Exane Lowers Price Target on Siegfried, Maintains Outperform Recommendation MT
Bank Vontobel Lowers Price Target on Siegfried, Maintains Buy Recommendation MT
Chart Siegfried Holding AG
More charts
Siegfried Holding AG is a Switzerland-based life sciences company which is active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and sterile. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States, China, and Spain.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
11
Last Close Price
907.5 CHF
Average target price
1,005 CHF
Spread / Average Target
+10.78%
Consensus
  1. Stock
  2. Equities
  3. Stock Siegfried Holding AG - Swiss Exchange
  4. News Siegfried Holding AG
  5. Siegfried : to Face Financial Impact of Cyberattack in H1